retatrutide and diarrhea (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic Mounjaro—but more powerful. The reason comes down to how it works Sulphur Burps and Diarrhoea from

Description

This class of drugs are frequently used by diabetologists for their strong glucose-lowering effects, beneficial safety profile as well as for their cardiovascular protection as described below

Standard escalation protocol The most widely used escalation schedule for compounded tirzepatide B12 formulations follows this structure

A rise in creatinine level up to 30% from baseline is an anticipated finding with drug initiation or dose modification and is due to the reduction in intraglomerular pressure

The risk becomes more clinically meaningful for patients with type 2 diabetes, particularly those also taking insulin or sulfonylureas

While this can lead to meaningful weight loss and better blood glucose control, it can also trigger changes that make you feel dizzy or off balanceespecially early in treatment